General Science Current Affairs Analysis
J&J not to enforce patents on TB drug
Bedaquiline is the first drug for tuberculosis, or TB.
It is less toxic and more effective than traditional TB treatments.
Sirturo — its brand name for bedaquiline, which is used in the treatment of multidrug-resistant tuberculosis
Not enforcing the patents provide unfettered access to affordable generic versions of bedaquiline for all people living with drug-resistant tuberculosis who need the drug in low- and middle-income countries.
Delamanid – TB Drug – Japan Company Otsuka
It is another key drug-resistant TB drug used in combination with bedaquiline, and is particularly important for the treatment of children.
"UPSC-2026-PRELIMS COMBINED MAINS PROGRAMME" NEW BATCH STARTS WITH ORIENTATION ON APRIL 14th,2025 "ECONOMIC SURVEY 2024-25"
"UNION BUDGET-2025-26 ANALYSIS"
TNPSC-2025 - GR-I, II, A and IV PCM NEW BATCH STARTS ON APRIL 14th, 2025
"TNPSC-2025 GROUP-I, II, A PRELIMS TEST SERIES"